The English website of the "Alessandra Graziottin Foundation" boosted on line

Back to Scientific Updates

06/03/2008

Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management

Bachmann G. Rosen R. Pinn V. Utian W. Ayers C. Basson R. Binik Y. Brown C. Foster D. Gibbons J. Goldstein I. Graziottin A. Haefner H. Harlow B. Kellogg Spadt S. Leiblum S. Masheb R. Reed B. Sobel J. Veasley C. Wesselmann U. Witkin S.
Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management
J Reprod Med. 2006 Jun; 51(6): 447-456

Vulvodynia is a prevalent and highly distressing disorder, with major consequences for interpersonal and psychologic well-being. The meeting on which this article is based was held in October 2004 in association with the Third Annual Meeting of the International Society of Women's Sexual Health. The areas that were addressed included the definition of vulvodynia, comorbid conditions, disease progression, diagnosis and workup of the patient, clinical management and reasearch needs.

By courtesy of Journal of Reproductive Medicine ®, Inc.

top

Available documents:
Full text of the article

09/11/2009 - Mast cells and their role in sexual pain disorders

16/06/2008 - Neuropathic pain in vulvar vestibulitis: Diagnosis and treatment

06/03/2008 - Vulvar Vestibulitis Syndrome: a Clinical Approach

Keywords:
Amytriptiline - Depression - Female Dyspareunia - Sexual Pain Disorders - Female Sexual Disorders - Neuropathic Pain - Nociceptive Pain - Nerve Growth Factor (NGF) - Gynaecology - Mastcells - Hyperactive Pelvic Floor - Uro-Gynaecologic Rehabilitation - Anthalgic Therapy - Behavioural Therapy - Vestibulectomy - Vulvar Vestibulitis/Vulvodynia

FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.fondazionegraziottin.org).

WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.

Back to Scientific Updates

C.F./P.IVA: 060 829 20 965

Terms and conditions - Privacy policy - Credits